- Home
- TILE vs IRON Comparison
TILE vs IRON Comparison
Compare TILE & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TILE
- IRON
- Stock Information
- Founded
- TILE 1973
- IRON 2017
- Country
- TILE United States
- IRON United States
- Employees
- TILE N/A
- IRON N/A
- Industry
- TILE Home Furnishings
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- TILE Consumer Discretionary
- IRON Health Care
- Exchange
- TILE Nasdaq
- IRON Nasdaq
- Market Cap
- TILE 1.1B
- IRON 839.3M
- IPO Year
- TILE N/A
- IRON N/A
- Fundamental
- Price
- TILE $17.80
- IRON $50.35
- Analyst Decision
- TILE Buy
- IRON Buy
- Analyst Count
- TILE 2
- IRON 8
- Target Price
- TILE $18.00
- IRON $64.13
- AVG Volume (30 Days)
- TILE 456.0K
- IRON 145.7K
- Earning Date
- TILE 11-01-2024
- IRON 08-08-2024
- Dividend Yield
- TILE 0.22%
- IRON N/A
- EPS Growth
- TILE 1272.24
- IRON N/A
- EPS
- TILE 1.13
- IRON N/A
- Revenue
- TILE $1,272,502,000.00
- IRON N/A
- Revenue This Year
- TILE $6.22
- IRON N/A
- Revenue Next Year
- TILE $3.43
- IRON N/A
- P/E Ratio
- TILE $15.76
- IRON N/A
- Revenue Growth
- TILE N/A
- IRON N/A
- 52 Week Low
- TILE $8.26
- IRON $25.60
- 52 Week High
- TILE $19.15
- IRON $77.60
- Technical
- Relative Strength Index (RSI)
- TILE 51.96
- IRON 61.60
- Support Level
- TILE $17.94
- IRON $48.69
- Resistance Level
- TILE $18.42
- IRON $51.11
- Average True Range (ATR)
- TILE 0.52
- IRON 2.23
- MACD
- TILE -0.06
- IRON 0.02
- Stochastic Oscillator
- TILE 36.02
- IRON 60.91
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments - AMS and EAAA.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.